Table 1 Demographic and medical characteristics of affected patients
From: Calcification of the internal elastic lamina of coronary arteries
Age | Sex | HIV status | Medical history a | Long-term medications | ARF a | CRF a |
|---|---|---|---|---|---|---|
51 | M | HIV+ | AIDS, diffuse B-cell lymphoma, PCP, TB, hypogonadism, cryptococcal meningitis, Guillain–Barre, smoking | Extensive antiretroviral exposure,b bupropion, epoetin alfa, megestrol acetate, trimethoprim-sulfamethoxazole, azithromycin, vitamin B, vitamin E, testosterone, pregabalin | + | − |
44 | F | HIV+ | AIDS, vasculitis, HBV, PCP, ITP, neuropathy, cocaine use, shingles | Extensive antiretroviral exposure, decadorabolin, paroxetine, valacyclovir, testosterone, epoetin alfa | ? | − |
44 | M | HIV+ | AIDS, HCV, HBV, hepatic encephalopathy, PCP, anemia, seizure disorder, cocaine use, schizophrenia | Extensive antiretroviral exposure Other: dapsone, azithromycin | − | − |
42 | M | HIV+ | AIDS, pneumonia, wasting, HCV, cryoglobulinemia, depression, HTN | Extensive antiretroviral exposure, thiamine, folate, hydrocortisone, vitamin K, aluminum hydroxide | + | − |
36 | M | HIV+ | AIDS, CNS lymphoma, PCP, KS, anemia, wasting, dementia, smoking, cocaine use, HSV, neutropenia | Extensive antiretroviral exposure, trimethoprim-sulfamethoxazole | − | − |
36 | F | HIV+ | AIDS, CMV retinitis/enteritis, MAC, pancytopenia, HCV, PCP, depression, dementia, seizure disorder, HTN, cocaine use | Extensive antiretroviral exposure, foscarnet, trimethoprim-sulfamethoxazole, azithromycin, filgrastim, methadone, epoetin alfa, citalopram, phenytoin, mirtazapine | − | − |
46 | M | HIV+ | AIDS, Stevens–Johnson syndrome, HCV, HBV | Unknown antiretroviral exposure, temazepam | − | − |
39 | M | HIV+ | AIDS, MAC, Parvovirus B19 pancytopenia, wasting | Extensive antiretroviral exposure, lansoprazole, amitriptyline, trimethoprim-sulfamethoxazole, acyclovir, azithromycin, paroxetine, tegretol, filgrastim, nandralone, delatestryl | ? | − |
37 | M | HIV+ | AIDS, HBV, syphilis, wasting | No antiretroviral exposure, atovaquone, azithromycin | − | − |
37 | M | HIV+ | AIDS, PML | Extensive antiretroviral exposure, filgrastim, atovaquone, azithromycin, venlafaxine, pantoprazole, magnesium | − | − |
51 | F | HIV− | Paraplegia due to HTLV-1 myelopathy, osteomyelitis of the coccyx | Citalopram, gabapentin, vitamin C, epoetin alfa, multivitamin, hydrocortisone | + | − |
63 | F | HIV− | ALS, CAD s/p stent, CHF, hypothyroidism, asthma, migraines, s/p hip replacement | Unknown | + | − |
61 | F | HIV− | ALS, CAD s/p MI, smoker, HTN, hyperlipidemia, depression | Riluzole, premarin, amitriptyline, sertraline | − | − |
64 | F | HIV− | ALS | Riluzole | − | − |
69 | F | HIV− | ALS, diabetes mellitus, osteoarthritis, hyperlipidemia, depression, sick sinus syndrome | Oral hypoglycemics, riluzole | − | − |
78 | M | HIV− | Metastatic prostate cancer, myelogenous leukemia, CAD, smoker | Unknown | − | − |
73 | F | HIV− | ALS | Unknown | ? | ? |
40 | M | HIV− | Unknown cause of death, cocaine use | Unknown | ? | ? |
27 | M | HIV− | Unknown cause of death, no known past medical history | Unknown | − | − |
